title: Prostaglandin E2 (PGE2) alters the pathogenesis of MHV-3 infection in susceptible BALB/cJ mice.
authors.affiliation: Toronto General Hospital, Ontario, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Abecassis
authors.forename: J
authors.initials: J
authors.lastname: Falk
authors.forename: V
authors.initials: V
authors.lastname: Dindzans
authors.forename: W
authors.initials: W
authors.lastname: Lopatin
authors.forename: L
authors.initials: L
authors.lastname: Makowka
authors.forename: G
authors.initials: G
authors.lastname: Levy
authors.forename: R
authors.initials: R
authors.lastname: Falk
mesh_terms: D015064:16,16-Dimethylprostaglandin E2 / Q000494:pharmacology*; D000818:Animals; D001779:Blood Coagulation Factors / Q000096:biosynthesis; D003588:Cytopathogenic Effect, Viral; D006524:Hepatitis, Viral, Animal / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D066298:In Vitro Techniques; D008264:Macrophages / Q000201:enzymology / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D006517:Murine hepatitis virus; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology*
chemical_list: D001779:Blood Coagulation Factors; D011459:Prostaglandins E, Synthetic; C045072:macrophage procoagulant activity; D015064:16,16-Dimethylprostaglandin E2